Does SIPULEUCEL-T Cause Infusion site extravasation? 22 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 22 reports of Infusion site extravasation have been filed in association with SIPULEUCEL-T (PROVENGE). This represents 0.5% of all adverse event reports for SIPULEUCEL-T.
22
Reports of Infusion site extravasation with SIPULEUCEL-T
0.5%
of all SIPULEUCEL-T reports
0
Deaths
1
Hospitalizations
How Dangerous Is Infusion site extravasation From SIPULEUCEL-T?
Of the 22 reports, 1 (4.5%) required hospitalization.
Is Infusion site extravasation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SIPULEUCEL-T. However, 22 reports have been filed with the FAERS database.
What Other Side Effects Does SIPULEUCEL-T Cause?
Chills (447)
Infusion related reaction (414)
Pyrexia (255)
Fatigue (249)
Malaise (233)
Nausea (205)
Disease progression (185)
Ill-defined disorder (185)
Culture positive (174)
Asthenia (164)
What Other Drugs Cause Infusion site extravasation?
HUMAN IMMUNOGLOBULIN G (822)
INFLIXIMAB (435)
INFLIXIMAB-DYYB (328)
TREPROSTINIL (256)
VEDOLIZUMAB (199)
HUMAN IMMUNOGLOBULIN G\HYALURONIDASE RECOMBINANT HUMAN (185)
REMDESIVIR (144)
FERRIC CARBOXYMALTOSE (118)
RITUXIMAB (82)
NATALIZUMAB (70)
Which SIPULEUCEL-T Alternatives Have Lower Infusion site extravasation Risk?
SIPULEUCEL-T vs SIROLIMUS
SIPULEUCEL-T vs SIRUKUMAB
SIPULEUCEL-T vs SITAGLIPTIN
SIPULEUCEL-T vs SOAP
SIPULEUCEL-T vs SODIUM